Teva Pharmaceutical Industries Ltd

TEVA

Company Profile

  • Business description

    Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

  • Contact

    124 Dvora HaNevi’a Street
    Tel Aviv6944020
    ISR

    T: +972 39148213

    E: [email protected]

    https://www.tevapharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    35,686

Teva Pharmaceutical Industries Ltd News & Analysis

stocks

4 stocks in Buffett's portfolio

These undervalued stocks are among the holdings in Berkshire Hathaway today.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,877.508.50-0.10%
CAC 408,113.5416.540.20%
DAX 4023,699.47110.030.47%
Dow JONES (US)47,289.33427.09-0.90%
FTSE 1009,724.3021.770.22%
HKSE26,095.0561.790.24%
NASDAQ23,275.9289.76-0.38%
Nikkei 22549,303.450.170.00%
NZX 50 Index13,502.7754.280.40%
S&P 5006,812.6336.46-0.53%
S&P/ASX 2008,579.707.60-0.09%
SSE Composite Index3,897.7116.29-0.42%

Market Movers